Abstract:mRNA technology has recently demonstrated the ability to significantly change the timeline for developing and delivering a new vaccine from years to months. The potential of mRNA technology for rapid vaccine development has recently been highlighted by the successful development and approval of two mRNA vaccines for COVID-19. Importantly, this RNA-based approach holds promise for treatments beyond vaccines and infectious diseases, e.g., treatments for cancer, metabolic disorders, cardiovascular conditions, and autoimmune diseases. There is currently significant demand for the development of improved manufacturing processes for the production of mRNA therapeutics in an effort to increase their yield and quality. The development of suitable analytical methods for the analysis of mRNA therapeutics is critical to underpin manufacturing development and the characterisation of the drug product and drug substance. In this study we have developed a high-throughput, high-performance liquid chromatography (HPLC) workflow for the rapid analysis of mRNA generated using in vitro transcription (IVT). We have optimised anion exchange (AEX) HPLC for the analysis of mRNA directly from IVT. Chromatography was performed in under 6 min enabling separation of all of the key components in the IVT, including nucleoside triphosphates (NTPs), Cap analogue, plasmid DNA and mRNA product. Moreover, baseline separation of the NTPs was achieved, which facilitates accurate quantification of each NTP such that their consumption may be determined during IVT reactions. Furthermore, the HPLC method was used to rapidly assess the purification of the mRNA product, including removal of NTPs/Cap analogue and other contaminants after downstream purification, including solid phase extraction (SPE), oligo deoxythymidine (oligo-dT) affinity chromatography and tangential flow filtration (TFF). Using the developed method excellent precision was obtained with calibration curves for an external mRNA standard and NTPs giving correlation coefficients of 0.98 and 1.0 respectively. Intra- and inter-day studies on retention time stability of NTPs, showed a relative standard deviation ≤ 0.3% and ≤1.5% respectively. The mRNA retention time variability was ≤0.13%. This method was then utilised to monitor the progress of an IVT reaction for the production of Covid spike protein (C-Spike) mRNA to measure the increasing yield of mRNA alongside the consumption of NTPs during the reaction.

Messenger RNA chromatographic purification: advances and challenges

Development of Polypeptide-Based Materials Toward Messenger RNA Delivery

Comprehensive Impurity Profiling of mRNA: Evaluating Current Technologies and Advanced Analytical Techniques

Enzymatic Isolation and Microfluidic Electrophoresis Analysis of Residual dsRNA Impurities in mRNA Vaccines and Therapeutics

Quality by design for mRNA platform purification based on continuous oligo-dT chromatography

High Recovery Chromatographic Purification of mRNA at Room Temperature and Neutral pH

Technologies and Challenges for MRNA: Current Situation Analysis and Outlook

mRNA Purification: Technology Aspects and Impurities TFF, Chromatography, UF/DF (Resins, Magnetic Beads, Monoliths)

Optimizing Messenger RNA Analysis Using Ultra-Wide Pore Size Exclusion Chromatography Columns

Purifying circular RNA by ultrafiltration

Exploring the Impact of In Vitro-Transcribed mRNA Impurities on Cellular Responses

Engineered mRNAs With Stable Structures Minimize Double-stranded RNA Formation and Increase Protein Expression

Engineered mRNA Delivery Systems for Biomedical Applications

Airway applied IVT mRNA vaccine needs specific sequence design and high standard purification that removes devastating dsRNA contaminant

Anion exchange HPLC monitoring of mRNA in vitro transcription reactions to support mRNA manufacturing process development

Exosome for mRNA delivery: strategies and therapeutic applications

Delivering the Messenger: Advances in Technologies for Therapeutic Mrna Delivery

Cellular Trafficking of Nanotechnology‐Mediated mRNA Delivery

The roles of polymers in mRNA delivery

Emerging Mrna Technologies: Delivery Strategies and Biomedical Applications.

Rapid and high recovery isolation of mRNA from in vitro transcription system by ammonium sulphate precipitation at room temperature